Christopher Weber to Cyclin-Dependent Kinase Inhibitor p21
This is a "connection" page, showing publications Christopher Weber has written about Cyclin-Dependent Kinase Inhibitor p21.
Connection Strength
0.026
-
Topical polyethylene glycol as a novel chemopreventive agent for oral cancer via targeting of epidermal growth factor response. PLoS One. 2012; 7(6):e38047.
Score: 0.026
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.